Compound 2019
Identifiers
- Common name: RO-5963
- Canonical SMILES:
Cc1c(Cl)ccc2c(C=C3NC(=O)N(C(C(=O)NC(CO)CO)c4ccc(F)c(F)c4)C3=O)c[nH]c12
- IUPAC name:
2-{4-[(6-chloro-7-methyl-1H-indol-3-yl)methylidene]-2,5-dioxoimidazolidin-1-yl}-2-(3,4-difluorophenyl)-N-(1,3-dihydroxypropan-2-yl)acetamide
- InChi:
InChI=1S/C24H21ClF2N4O5/c1-11-16(25)4-3-15-13(8-28-20(11)15)7-19-23(35)31(24(36)30-19)21(22(34)29-14(9-32)10-33)12-2-5-17(26)18(27)6-12/h2-8,14,21,28,32-33H,9-10H2,1H3,(H,29,34)(H,30,36)
- InChiKey:
ZFYQBPVMECJUBO-UHFFFAOYSA-N
External links
![]() 72681826 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-like dimer | 7.76 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 518.12 g/mol | |||
HBA | 9 | |||
HBD | 5 | |||
HBA + HBD | 14 | |||
AlogP | 1.91 | |||
TPSA | 134.76 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1073/pnas.1203789109 | RO-5963 | MDM4 O15151 |
|
Biochemical assay | Trp fluorescence quenching MDM2 | pIC50 (half maximal inhibitory concentration, -log10) | 7.76 | |
10.1073/pnas.1203789109 | RO-5963 | MDM4 O15151 |
|
Biochemical assay | Trp fluorescence quenching MDMX | pIC50 (half maximal inhibitory concentration, -log10) | 7.61 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5087 | LY-2090314 | DB11913 | |
0.4732 | Talmapimod | DB05412 | |
0.4706 | 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione | DB01772 | |
0.4669 | Enzastaurin | DB06486 | |
0.4592 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE | DB08063 | |
0.4538 | 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid | DB03104 | |
0.4522 | Vorolanib | DB15247 | |
0.4464 | 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE | DB07457 | |
0.4464 | Bisindolylmaleimide VIII | DB01946 | |
0.4462 | Sotrastaurin | DB12369 | |
0.4454 | 3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione | DB07456 | |
0.4454 | 3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione | DB07458 | |
0.4430 | ACT-451840 | DB13054 | |
0.4426 | MKC-1 | DB05608 | |
0.4425 | Bisindolylmaleimide I | DB03777 |